These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 15588125

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Blockade of endothelin receptors attenuates end-organ damage in homozygous hypertensive ren-2 transgenic rats.
    Dvorák P, Kramer HJ, Bäcker A, Malý J, Kopkan L, Vanecková I, Vernerová Z, Opocenský M, Tesar V, Bader M, Ganten D, Janda J, Cervenka L.
    Kidney Blood Press Res; 2004; 27(4):248-58. PubMed ID: 15286437
    [Abstract] [Full Text] [Related]

  • 3. Early endothelin-A receptor blockade decreases blood pressure and ameliorates end-organ damage in homozygous Ren-2 rats.
    Vanêcková I, Kramer HJ, Bäcker A, Vernerová Z, Opocensky M, Cervenka L.
    Hypertension; 2005 Oct; 46(4):969-74. PubMed ID: 16157796
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. End-organ damage in hypertensive transgenic Ren-2 rats: influence of early and late endothelin receptor blockade.
    Vernerová Z, Kujal P, Kramer HJ, Bäcker A, Cervenka L, Vaneckova I.
    Physiol Res; 2009 Oct; 58 Suppl 2():S69-S78. PubMed ID: 20131938
    [Abstract] [Full Text] [Related]

  • 6. Effects of changes in sodium balance on plasma and kidney angiotensin II levels in anesthetized and conscious Ren-2 transgenic rats.
    Husková Z, Kramer HJ, Vanourková Z, Cervenka L.
    J Hypertens; 2006 Mar; 24(3):517-27. PubMed ID: 16467655
    [Abstract] [Full Text] [Related]

  • 7. Distinct effects of bosentan on NO-dependent vasodilation and calcium influx in heterozygous Ren-2 transgenic rats on high-salt diet.
    Vaněčková I, Hojná S, Kadlecová M, Kompanowska-Jezierska E, Zicha J.
    Physiol Res; 2019 Oct 25; 68(5):717-725. PubMed ID: 31424254
    [Abstract] [Full Text] [Related]

  • 8. Early-onset endothelin receptor blockade in hypertensive heterozygous Ren-2 rats.
    Vanecková I, Kramer HJ, Bäcker A, Schejbalová S, Vernerová Z, Eis V, Opocenský M, Dvorák P, Cervenka L.
    Vascul Pharmacol; 2006 Sep 25; 45(3):163-70. PubMed ID: 16807127
    [Abstract] [Full Text] [Related]

  • 9. Late-onset endothelin-A receptor blockade reduces podocyte injury in homozygous Ren-2 rats despite severe hypertension.
    Opocenský M, Kramer HJ, Bäcker A, Vernerová Z, Eis V, Cervenka L, Certíková Chábová V, Tesar V, Vanecková I.
    Hypertension; 2006 Nov 25; 48(5):965-71. PubMed ID: 17015777
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of dietary salt load and salt depletion on the course of hypertension and angiotensin II levels in male and female heterozygous Ren-2 transgenic rats.
    Husková Z, Kramer H, Vanourková Z, Thumová M, Malý J, Opocenský M, Skaroupková P, Kolský A, Vernerová Z, Cervenka L.
    Kidney Blood Press Res; 2007 Nov 25; 30(1):45-55. PubMed ID: 17259738
    [Abstract] [Full Text] [Related]

  • 12. Acute effects of cyclooxygenase-2 inhibition on renal function in heterozygous ren-2-transgenic rats on normal or low sodium intake.
    Vanecková I, Cahová M, Kramer HJ, Husková Z, Skaroupková P, Komers R, Bader M, Ganten D, Cervenka L.
    Kidney Blood Press Res; 2004 Nov 25; 27(4):203-10. PubMed ID: 15273422
    [Abstract] [Full Text] [Related]

  • 13. Effects of chronic cytochrome P-450 inhibition on the course of hypertension and end-organ damage in Ren-2 transgenic rats.
    Chábová VC, Kramer HJ, Vanecková I, Vernerová Z, Eis V, Tesar V, Skaroupková P, Thumová M, Schejbalová S, Husková Z, Vanourková Z, Kolský A, Imig JD, Cervenka L.
    Vascul Pharmacol; 2007 Nov 25; 47(2-3):145-59. PubMed ID: 17604232
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Endothelin receptor blockade does not affect blood pressure or angiotensin II levels in CYP1A1-Ren-2 transgenic rats with acutely induced hypertension.
    Vanourková Z, Kramer HJ, Erbanová M, Bäcker A, Cervenka L, Husková Z, Chábová VC, Tesar V, Dvorák P, Malý J, Vanecková I.
    Vascul Pharmacol; 2009 Nov 25; 50(5-6):194-9. PubMed ID: 19563737
    [Abstract] [Full Text] [Related]

  • 18. Endothelin A receptor blocker atrasentan lowers blood pressure by the reduction of nifedipine-sensitive calcium influx in Ren-2 transgenic rats fed a high-salt diet.
    Vaněčková I, Dobešová Z, Kuneš J, Vernerová Z, Zicha J.
    J Hypertens; 2015 Jan 25; 33(1):161-9. PubMed ID: 25255392
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.